HuGE Literature Finder
Records
1
-
20
| Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma. Investigational new drugs 2021 Mar . Zauderer Marjorie G, Alley Evan W, Bendell Johanna, Capelletto Enrica, Bauer Todd M, Callies Sophie, Szpurka Anna M, Kang Suhyun, Willard Melinda D, Wacheck Volker, Varghese Anna |
| Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Apr . Pirker Christine, Bilecz Agnes, Grusch Michael, Mohr Thomas, Heidenreich Barbara, Laszlo Viktoria, Stockhammer Paul, Lötsch-Gojo Daniela, Gojo Johannes, Gabler Lisa, Spiegl-Kreinecker Sabine, Doeme Balazs, Steindl Ariane, Klikovits Thomas, Hoda Mir Alireza, Jakopovic Marko, Samarzija Miroslav, Mohorcic Katja, Kern Izidor, Kiesel Barbara, Brcic Luka, Oberndorfer Felicitas, Müllauer Leonhard, Klepetko Walter, Schmidt Wolfgang M, Kumar Rajiv, Hegedus Balazs, Berger Walt |
| Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Aug JCO2018785204. Panou Vasiliki, Gadiraju Meghana, Wolin Arthur, Weipert Caroline M, Skarda Emily, Husain Aliya N, Patel Jyoti D, Rose Buerkley, Zhang Shannon R, Weatherly Madison, Nelakuditi Viswateja, Knight Johnson Amy, Helgeson Maria, Fischer David, Desai Arpita, Sulai Nanna, Ritterhouse Lauren, Røe Oluf D, Turaga Kiran K, Huo Dezheng, Segal Jeremy, Kadri Sabah, Li Zejuan, Kindler Hedy L, Churpek Jane |
| Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget 2017 Sep 8 (43): 74936-74946. Lin Moubin, Zhang Liren, Hildebrandt Michelle A T, Huang Maosheng, Wu Xifeng, Ye Yuanqi |
| BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Dec . Leblay Noémie, Leprêtre Frédéric, Le Stang Nolwenn, Gautier-Stein Amandine, Villeneuve Laurent, Isaac Sylvie, Maillet Denis, Galateau-Sallé Françoise, Villenet Céline, Sebda Shéhérazade, Goracci Alexandra, Byrnes Graham, McKay James D, Figeac Martin, Glehen Olivier, Gilly François-Noël, Foll Matthieu, Fernandez-Cuesta Lynnette, Brevet Mar |
| BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. Journal of gastrointestinal oncology 2016 Aug 7 (4): 556-61. Al-Shamsi Humaid O, Anand Deepa, Shroff Rachna T, Jain Apurva, Zuo Mingxin, Conrad Claudius, Vauthey Jean-Nicolas, Javle Milind |
| CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Cancer letters 2016 May . Betti M, Aspesi A, Biasi A, Casalone E, Ferrante D, Ogliara P, Gironi L C, Giorgione R, Farinelli P, Grosso F, Libener R, Rosato S, Turchetti D, Maffè A, Casadio C, Ascoli V, Dianzani C, Colombo E, Piccolini E, Pavesi M, Miccoli S, Mirabelli D, Bracco C, Righi L, Boldorini R, Papotti M, Matullo G, Magnani C, Pasini B, Dianzani |
| Risk of second primary cancers after malignant mesothelioma and vice versa. Cancer letters 2016 May 379 (1): 94-99. Chen Tianhui, Kharazmi Elham, Lou Jianlin, Zhang Xing, Sundquist Kristina, Hemminki Ka |
| Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta-analysis. Genes, chromosomes & cancer 2016 10 55 (10): 741-9. Luchini Claudio, Veronese Nicola, Yachida Shinichi, Cheng Liang, Nottegar Alessia, Stubbs Brendon, Solmi Marco, Capelli Paola, Pea Antonio, Barbareschi Mattia, Fassan Matteo, Wood Laura D, Scarpa Al |
| Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Cancer research 2015 Dec . Ohar Jill A, Cheung Mitchell, Talarchek Jacqueline, Howard Suzanne E, Howard Timothy D, Hesdorffer Mary, Peng Hongzhuang, Rauscher Frank J, Testa Joseph |
| Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing. Lung 2015 Oct . Mäki-Nevala Satu, Sarhadi Virinder Kaur, Knuuttila Aija, Scheinin Ilari, Ellonen Pekka, Lagström Sonja, Rönty Mikko, Kettunen Eeva, Husgafvel-Pursiainen Kirsti, Wolff Henrik, Knuutila Saka |
| Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma. Gene 2015 May 563 (1): 103-5. Sneddon Sophie, Leon Justine S, Dick Ian M, Cadby Gemma, Olsen Nola, Brims Fraser, Allcock Richard J N, Moses Eric K, Melton Phillip E, de Klerk Nicholas, Musk A W Bill, Robinson Bruce W S, Creaney Jenet |
| High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Apr 10 (4): 565-76. Nasu Masaki, Emi Mitsuru, Pastorino Sandra, Tanji Mika, Powers Amy, Luk Hugh, Baumann Francine, Zhang Yu-An, Gazdar Adi, Kanodia Shreya, Tiirikainen Maarit, Flores Erin, Gaudino Giovanni, Becich Michael J, Pass Harvey I, Yang Haining, Carbone Miche |
| Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Mar 10 (3): 492-9. Lo Iacono Marco, Monica Valentina, Righi Luisella, Grosso Federica, Libener Roberta, Vatrano Simona, Bironzo Paolo, Novello Silvia, Musmeci Loredana, Volante Marco, Papotti Mauro, Scagliotti Giorgio |
| Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis 2015 Jan 36 (1): 76-81. Baumann Francine, Flores Erin, Napolitano Andrea, Kanodia Shreya, Taioli Emanuela, Pass Harvey, Yang Haining, Carbone Miche |
| Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung cancer (Amsterdam, Netherlands) 2015 Jan 87 (1): 77-9. Rusch Andreas, Ziltener Gabriela, Nackaerts Kristiaan, Weder Walter, Stahel Rolf A, Felley-Bosco Emanue |
| Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer research 2015 Jan 75 (2): 264-9. Guo Guangwu, Chmielecki Juliann, Goparaju Chandra, Heguy Adriana, Dolgalev Igor, Carbone Michele, Seepo Sara, Meyerson Matthew, Pass Harvey |
| Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition. PloS one 2015 10 (3): e0122662. Wadt Karin A W, Aoude Lauren G, Krogh Lotte, Sunde Lone, Bojesen Anders, Grønskov Karen, Wartacz Nine, Ek Jakob, Tolstrup-Andersen Morten, Klarskov-Andersen Mette, Borg Åke, Heegaard Steffen, Kiilgaard Jens F, Hansen Thomas V O, Klein Kerenaftali, Jönsson Göran, Drzewiecki Krzysztof T, Dunø Morten, Hayward Nicholas K, Gerdes Anne-Mar |
| Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Nov 8 (11): 1430-3. Zauderer Marjorie G, Bott Matthew, McMillan Robert, Sima Camelia S, Rusch Valerie, Krug Lee M, Ladanyi Ma |
| BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Journal of translational medicine 2012 Aug 10 (1): 1. Carbone M, Korb Ferris L, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: